Tissue Engineered Medical Products
ASTM International’s committee on medical and surgical materials and devices (F04) invites all interested parties to participate in the revision of the terminology standard (F2312) for tissue-engineered medical products (TEMP).
“The value in this standard is that it allows for clearer communication between different facets of the field helping to get products developed more efficiently and decrease the potential for misunderstandings,” says ASTM International member Katie Zander, scientific program manager, Standards Coordinating Body for Regenerative Medicine. “This terminology standard is useful to anyone working with TEMPs, including those in academia, industry, clinical work, standards development organizations, and government organizations.”
Zander notes that anyone involved in TEMP development, particularly those working on cell and tissue therapies as they apply to TEMPs, is welcome to help the terminology subcommittee in reviewing terms to be included in this revision.
In addition to the terminology standard, the subcommittee is also now revising its standard on classification of cellular and/or tissue-based products for skin wounds (F3163), as terminology in this standard will be affected by the terminology revision.
ASTM welcomes participation in the development of its standards. Become a member of ASTM.